title: Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA λ.
authors.forename: Marta
authors.initials: M
authors.lastname: Carlesimo
authors.forename: Alessandra
authors.initials: A
authors.lastname: Narcisi
authors.forename: Diego
authors.initials: D
authors.lastname: Orsini
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Di Russo
authors.forename: Giorgia
authors.initials: G
authors.lastname: Cortesi
authors.forename: Giacinto
authors.initials: G
authors.lastname: La Verde
authors.forename: Maria
authors.initials: M
authors.lastname: Giubettini
authors.forename: Federica
authors.initials: F
authors.lastname: Pulcini
authors.forename: Germana
authors.initials: G
authors.lastname: Camplone
mesh_terms: D000368:Aged; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood; D007146:Immunoglobulin lambda-Chains; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D019653:Myeloablative Agonists / Q000008:administration & dosage; D010257:Paraneoplastic Syndromes / Q000150:complications* / Q000188:drug therapy; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000150:complications* / Q000188:drug therapy
chemical_list: D005938:Glucocorticoids; D007070:Immunoglobulin A; D007146:Immunoglobulin lambda-Chains; D019653:Myeloablative Agonists; D003907:Dexamethasone; D008558:Melphalan